Appointments

513.221.1100 or 800.325.7787

Office locations

Mayfield Brain & Spine

3825 Edwards Road, Suite 300

Cincinnati, Ohio 45209

Donald P. Carruthers, MD

Physical Medicine and Rehabilitation Specialist

Areas of expertise - physical medicine and rehabilitation; interventional spinal procedures and therapies, such as joint injections, epidural steroid injections, facet joint injections, spinal cord stimulation; treatment of low back pain, neck pain, disc herniation, spinal stenosis

Education

  • Undergraduate: Massachusetts College of Pharmacy and Allied Health Sciences, 1985
  • Medical School: Ross University School of Medicine, Dominica, West Indies, 1998
  • Residency: Physical Medicine and Rehabilitation, University of Cincinnati College of Medicine, 1998-2002

Certification

    American Board of Physical Medicine and Rehabilitation

Experience

  • Mayfield Brain and Spine, Cincinnati: Physical Medicine and Rehabilitation Specialist, 2009-2014, 2016-present
  • Group Health TriHealth Physician Partners: Physical Medicine and Rehabilitation Specialist, 2002-2016; Director, Physical Medicine and Rehabilitation Department, 2014-2016
  • Select Specialty Hospital, Cincinnati: Medical Director of Neurorehabilitation, 2008-2015
  • MARC, Inc., Cincinnati: Medical Director of Neurorehabilitation, 2004-2012
  • Eckerd Drug Company, Tampa, Florida: Pharmacist and Pharmacy Manager, 1985-1994

Primary hospital affiliations*

Bethesda Butler Hospital, Good Samaritan Hospital, Mayfield Spine Surgery Center, Mayfield Procedure Suite

*Mayfield is affiliated with most major hospitals in Cincinnati and Northern Kentucky

Professional memberships

  • American Academy of Physical Medicine and Rehabilitation
  • American Medical Association
  • International Spine Intervention Society
  • Cincinnati Academy of Medicine
  • Ohio State Medical Association

Related links

Seventeen Mayfield Specialists Named to Regional and National 'Top Doctors' Lists

Sylvia's story: Back pain, epilepsy & carpal tunnel

New life for Celebrex (and arthritis sufferers) after clinical trial